It is well know that companies like to list on NASDAQ at as high a price possible but without a price too high which would instigate selling on day1.
I have a suspicion that the price is being maintained at these levels on purpose so that an upward trajectory can be gained only once Unilife lists on NASDAQ.
However, having said that, I am not at all sure how interested parties can be prevented from swamping the capper and sellers once further news has been announced.
On that subject, do we have any guesses as to what is next? 1ml production news , or perhaps seeing that Unilife have received SA's drug list (and see it as fair), that maybe this is what will be received next. Surely it can only be a case of signing on the dotted line now?
Add to My Watchlist
What is My Watchlist?
